Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05854017 · ClinicalTrials.gov registry record · NA
Effects of a Theanine for Stress Relief Formulation in Individuals Who Report Occasional Moderate High Levels of Stress.
A NA study of Stress, sponsored by Supplement Formulators.
- Active
- Registry status
- NA
- Development phase
- 104
- Enrollment target
- 1
- Study location
NCT05854017: Active NA study of Stress, sponsored by Supplement Formulators.
NCT05854017 is a NA study of Stress that is active but no longer recruiting, run by Supplement Formulators. The registered enrollment target is 104 participants, below the 785-participant average among 152 other Stress trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05854017, a NA study of Stress, is active but no longer recruiting, sponsored by Supplement Formulators.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the effectiveness and safety of the theanine for stress relief formulation versus placebo on stress, burnout component, mood and sleep
Primary Outcome
Assessment of the mean change in the results of the Perceived Stress Scale (PSS-14) from baseline. There are 14 items and total scores range from 0-56. The lower the score indicates a lower level of stress.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Theanine for stress relief formulation
Study Locations (1)
Florida
- Life Extension Clinical Research, Inc. - Fort Lauderdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2023-02-09 |
| Est. Completion | 2025-08-20 |
| Phase | NA |
What the registry record for NCT05854017 still lists
NCT05854017 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 785-participant average among 152 other Stress trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Stress appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05854017 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05854017 about?
NCT05854017 is a clinical study titled "Effects of a Theanine for Stress Relief Formulation in Individuals Who Report Occasional Moderate High Levels of Stress.". The purpose of this study is to assess the effectiveness and safety of the theanine for stress relief formulation versus placebo on stress, burnout component, mood and sleep
What is the current status of trial NCT05854017?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 104 participants. The study started on 2023-02-09. Estimated completion is 2025-08-20.
What conditions does trial NCT05854017 study?
This clinical trial studies the following conditions: Stress.
What interventions are being tested in trial NCT05854017?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Theanine for stress relief formulation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05854017?
This trial is sponsored by Supplement Formulators, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05854017 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05854017's enrollment target sits among peer trials
104 64th of 152 higher than 89 of 152 other Stress trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mindfulness-Based Intervention With a Supplement for Stress-Related Problems in College Students Across Multiple Sites (4SITE)
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
RECRUITING · NA
-
ACT for HIV-Positive Men
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI